|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07D 401/14 | |
| C07D 401/04 | |||
| C07D 417/04 | |||
| C07D 417/14 | |||
| C07D 471/04 | |||
| C07D 487/04 | |||
| A61K 31/4427 | |||
| A61P 35/00 |
| (11) | Number of the document | 3129367 |
| (13) | Kind of document | T |
| (96) | European patent application number | 15716690.1 |
| Date of filing the European patent application | 2015-04-02 | |
| (97) | Date of publication of the European application | 2017-02-15 |
| (45) | Date of publication and mention of the grant of the patent | 2019-09-04 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2015/024146 |
| Date | 2015-04-02 |
| (87) | Number | WO 2015/157093 |
| Date | 2015-10-15 |
| (30) | Number | Date | Country code |
| 201461976880 P | 2014-04-08 | US | |
| 201462019577 P | 2014-07-01 | US |
| (72) |
SINGH, Rajinder, US
BHAMIDIPATI, Somasekhar, US
DING, Pingyu, US
PAYAN, Donald, US
GELMAN, Marina, US
KINSELLA, Todd, US
|
| (73) |
Rigel Pharmaceuticals, Inc.,
1180 Veterans Boulevard, South San Francisco, CA 94080,
US
|
| (54) | 2,3-DISUBSTITUTED PYRIDINE COMPOUNDS AS TGF-BETA INHIBITORS |
| 2,3-DISUBSTITUTED PYRIDINE COMPOUNDS AS TGF-BETA INHIBITORS |